Letter: predictive factors for treatment discontinuation in IBD—anti‐TNF trough levels and anti‐drug antibodies

LINKED CONTENT This article is linked to Tournier et al and Roblin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16333 and https://doi.org/10.1111/apt.16501